ERBB2 and breast cancer: Conjugation of a single-chain fragment antibody against HER2 to doxorubicin-loaded liposomes led to higher doxorubicin accumulation in breast cancer xenografts and better tumor control than untargeted PEGylated doxorubicin-loaded liposomes [100].